CTD-MT 6.25/25/40 Tablet ER

Overview CTD-MT 6.25/25/40 Tablet ER

The extended-release combination medication, CTD-MT 6.25/25/40 mg tablet, effectively manages hypertension by promoting vasodilation and enhancing cardiac output. Its diuretic action eliminates excess fluid and electrolytes. Administer this medication at the same time each day, with or without food, preferably during daylight hours or at least four hours before sleep to minimize nocturnal urination. Dosage and frequency are determined by your physician based on individual needs and should be adhered to as prescribed. Common side effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of renal function and electrolyte levels is crucial. Optimal outcomes are achieved when coupled with lifestyle modifications including balanced nutrition, regular physical activity, and smoking cessation. Increased fluid intake is recommended to mitigate potential dryness and thirst. Prior to commencing treatment, inform your physician of any existing cardiovascular conditions, hepatic or renal impairment, or pregnancy. Complete disclosure of all other medications is essential, as drug interactions may compromise efficacy or alter the drug's mechanism of action.

Uses of CTD-MT 6.25/25/40 Tablet ER

Elevated blood pressure

Major Benefits of CTD-MT 6.25/25/40 Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-MT 6.25/25/40 Extended-Release tablet can be consumed with or without food, though consistent timing is recommended.

Common Side effects of CTD-MT 6.25/25/40 Tablet ER:

• Nausea
• Taste change
• Diarrhea
• Upset stomach
• Headache
• Dizziness
• Weakness
• Cold extremities
• Numbness of extremity
• Increased uric acid level in blood
• Increased blood lipid level
• Decreased magnesium level in blood
• Slow heart rate
• Decreased sodium level in blood
• Decreased blood pressure

How to use CTD-MT 6.25/25/40 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. CTD-MT 6.25/25/40 Extended Release tablets can be consumed with or without food, though consistent daily timing is recommended.

How CTD-MT 6.25/25/40 Tablet ER works:

The extended-release tablet CTD-MT 6.25/25/40 mg combines chlorthalidone, metoprolol succinate, and telmisartan to provide effective blood pressure reduction.

What if you forget to take CTD-MT 6.25/25/40 Tablet ER :

Should you forget a dose of your CTD-MT 6.25/25/40 Extended-Release tablet, take it immediately if feasible. Otherwise, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.